← Leaderboards
Anne M Vanbuskirk
Ohio State University
$616,796
Attributed
$616,796
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $74.8K · FY2005–07$100K$75K$50K$25K$0
'05
'06
'07
Funding mix
By agency
NIH$616,796 · 5
By mechanism
R03$371,750 · 3
R29$222,261 · 1
R21$22,785 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Susan R Mallery$15,292,540
- Christopher M Weghorst$9,056,160
- Tatiana M Oberyszyn$5,838,919
- Steven K Clinton$5,749,067
- Purnima Kumar$6,947,763
Others in their field
Top investigators on “Enzyme Linked Immunosorbent Assay”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,730,646
- Philip Louis Felgner · Gene Therapy Systems, Inc.$41,441,562
- Marianne Ward · Duke University$21,475,073
- Andrew B Norman · University Of Cincinnati$21,321,632
- Eric S. Orwoll · Oregon Health And Science University$20,906,524
- Andrew E. Levin · Immunetics, Inc.$20,730,152
Research focus
Enzyme Linked Immunosorbent AssayInterferon GammaHuman SubjectClinical ResearchScid MouseAntigen Presenting CellHelper T LymphocyteCytotoxic T LymphocytePostoperative ComplicationsTransplantationTransplantation ImmunologyEpstein Barr VirusVirus Related Neoplasm /CancerLymphomaCarcinogenesisFlow CytometryB LymphocyteHomologous TransplantationHairless MouseGenetically Modified AnimalsHeart TransplantationHumoral ImmunityDrug Related Neoplasm /CancerDisease /Disorder Proneness /Risk
Grant awards (8)
Inhibition of UVB-induced inflammation and carcinogenesis by black raspberry extr$22,785
R21 · FY2007 · AT · contact PI
Model for the Prevention of Post-Transplant Skin Cancer$74,750
R03 · FY2005 · CA
Model for the Prevention of Post-Transplant Skin Cancer$74,750
R03 · FY2004 · CA
PTLD: cytokine production and gene polymorphisms$74,750
R03 · FY2004 · CA
In vivo testing of the role of TGFb in PTLD$73,750
R03 · FY2003 · AI
In vivo testing of the role of TGFb in PTLD$73,750
R03 · FY2002 · AI
PRECLINICAL ANALYSIS OF DTH IN TRANSPLANT RECIPIENTS$105,869
R29 · FY2001 · AI
PRECLINICAL ANALYSIS OF DTH IN TRANSPLANT RECIPIENTS$116,392
R29 · FY2000 · AI